Joris Vundelinckx
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Joris Vundelinckx has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Dieter Mesotten
Ziekenhuis Oost-Limburg
1 shared publication- Dieter Mesotten
Department of Medicine and Life Sciences, Hasselt University, Diepenbeek, Belgium
1 shared publication Elly Vandermeulen
Ziekenhuis Oost-Limburg
1 shared publicationHans Goethuys
Ziekenhuis Oost-Limburg
1 shared publication- Hendrik Stragier
Department of Anaesthesiology, Intensive Care Medicine, Emergency Medicine and Pain Therapy, Ziekenhuis Oost-Limburg, Genk, Belgium
1 shared publication - Jasmin Verbist
Department of Anesthesiology, Intensive Care Medicine, Emergency Medicine and Pain Therapy, Ziekenhuis Oost-Limburg, Genk, Belgium
1 shared publication
Latest Publications
- Open Access
- 22 December 2022
- Published by Springer Nature in BMC Research Notes
- Vol. 15 (1) , 1-7
A comparative study of patient satisfaction about anesthesia with dexmedetomidine for ambulatory dental surgery
Objective: Intranasal administration of dexmedetomidine for monitored anesthesia care (MAC) appears to be an effective, safe, and appropriate alternative to general anesthesia (GA) for ambulatory dental surgery. Based on the available evidence we evaluated a new MAC protocol with intranasal dexmedetomidine as the primary choice. To assess a difference in patient satisfaction and anesthesia-related discomfort between GA and MAC in ambulatory dental surgery, a study was conducted among patients undergoing various dental procedures. Patient satisfaction and anesthesia-related discomfort were assessed on the first postoperative day using the Bauer patient satisfaction questionnaire. Results: Although the differences were small, patients in the MAC group were overall more satisfied with the general care compared to the GA group (p < 0.02). Patients in the MAC group reported more postoperative drowsiness compared to the GA group (p < 0.05), but less postoperative hoarseness and sore throat (p = 0.005 and p < 0.001, respectively). Moreover, postoperative thirst was more common in the GA group (p = 0.002). In conclusion, the differences in patient satisfaction and anesthesia-related discomfort between GA and MAC in this implementation study were small but appeared to favor MAC with intranasal dexmedetomidine over GA as anesthesia method during dental ambulatory surgery.
- 22 December 2022
- Published by Springer Nature in BMC Research Notes
- Vol. 15 (1) , 1-7
Open AccessA comparative study of patient satisfaction about anesthesia with dexmedetomidine for ambulatory dental surgery
Objective: Intranasal administration of dexmedetomidine for monitored anesthesia care (MAC) appears to be an effective, safe, and appropriate alternative to general anesthesia (GA) for ambulatory dental surgery. Based on the available evidence we evaluated a new MAC protocol with intranasal dexmedetomidine as the primary choice. To assess a difference in patient satisfaction and anesthesia-related discomfort between GA and MAC in ambulatory dental surgery, a study was conducted among patients undergoing various dental procedures. Patient satisfaction and anesthesia-related discomfort were assessed on the first postoperative day using the Bauer patient satisfaction questionnaire. Results: Although the differences were small, patients in the MAC group were overall more satisfied with the general care compared to the GA group (p < 0.02). Patients in the MAC group reported more postoperative drowsiness compared to the GA group (p < 0.05), but less postoperative hoarseness and sore throat (p = 0.005 and p < 0.001, respectively). Moreover, postoperative thirst was more common in the GA group (p = 0.002). In conclusion, the differences in patient satisfaction and anesthesia-related discomfort between GA and MAC in this implementation study were small but appeared to favor MAC with intranasal dexmedetomidine over GA as anesthesia method during dental ambulatory surgery.
- Open Access
- 10 March 2021
- Published by Springer Nature in Research Square
Intranasal dexmedetomidine to facilitate mask induction and prevent emergence delirium.
Background As children are exposed to stress and anxiety during the perioperative period, pre-anaesthetic medication to facilitate induction of anaesthesia without prolonging recovery is needed. Dexmedetomidine is increasingly being used for sedation in the intensive care units and for procedural anaesthesia outside the operating room. However, the effectiveness of pre-operative sedation with intranasal dexmedetomidine in paediatric patients undergoing ambulatory surgery has not yet been well characterised. Aims To identify the effectiveness of intranasal dexmedetomidine in facilitating mask induction and preventing emergence agitation. Methods In a single centre retrospective implementation study, we compared intranasal dexmedetomidine (2 µg/kg) administration, sequentially in all paediatric patients undergoing minor urological surgery between January 2019 and July 2019 with a period in which dexmedetomidine was not administered. The outcome measures were tolerance of mask induction, post-operative sedation and the Paediatric Anaesthesia Emergence Delirium scale (PAED) score. Results The 53 children in the control group were compared with 50 children in the dexmedetomidine group during implementation. The incidence of sedation on mask induction was greater in patients given dexmedetomidine compared to those who did not receive premedication (60% versus 0%, pConclusion In paediatric patients undergoing small urologic surgery, premedication with intranasal dexmedetomidine in a dose of 2µg/kg provides adequate sedation and anxiolysis on mask induction and in the postoperative period. These results from an implementation study need to be confirmed in a multicentre blinded randomised controlled trial.
- 10 March 2021
- Published by Springer Nature in Research Square
Open AccessIntranasal dexmedetomidine to facilitate mask induction and prevent emergence delirium.
Background As children are exposed to stress and anxiety during the perioperative period, pre-anaesthetic medication to facilitate induction of anaesthesia without prolonging recovery is needed. Dexmedetomidine is increasingly being used for sedation in the intensive care units and for procedural anaesthesia outside the operating room. However, the effectiveness of pre-operative sedation with intranasal dexmedetomidine in paediatric patients undergoing ambulatory surgery has not yet been well characterised. Aims To identify the effectiveness of intranasal dexmedetomidine in facilitating mask induction and preventing emergence agitation. Methods In a single centre retrospective implementation study, we compared intranasal dexmedetomidine (2 µg/kg) administration, sequentially in all paediatric patients undergoing minor urological surgery between January 2019 and July 2019 with a period in which dexmedetomidine was not administered. The outcome measures were tolerance of mask induction, post-operative sedation and the Paediatric Anaesthesia Emergence Delirium scale (PAED) score. Results The 53 children in the control group were compared with 50 children in the dexmedetomidine group during implementation. The incidence of sedation on mask induction was greater in patients given dexmedetomidine compared to those who did not receive premedication (60% versus 0%, pConclusion In paediatric patients undergoing small urologic surgery, premedication with intranasal dexmedetomidine in a dose of 2µg/kg provides adequate sedation and anxiolysis on mask induction and in the postoperative period. These results from an implementation study need to be confirmed in a multicentre blinded randomised controlled trial.